Cite
[How I treat ... atopic dermatitis by topical pimecrolimus (Elidel). The emerging paradigm of calcineurin inhibitors].
MLA
Piérard-Franchimont, C., et al. “[How I Treat ... Atopic Dermatitis by Topical Pimecrolimus (Elidel). The Emerging Paradigm of Calcineurin Inhibitors].” Revue Medicale de Liege, vol. 60, no. 3, Mar. 2005, pp. 136–40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15884695&authtype=sso&custid=ns315887.
APA
Piérard-Franchimont, C., Quatresooz, P., & Piérard, G. E. (2005). [How I treat ... atopic dermatitis by topical pimecrolimus (Elidel). The emerging paradigm of calcineurin inhibitors]. Revue Medicale de Liege, 60(3), 136–140.
Chicago
Piérard-Franchimont, C, P Quatresooz, and G E Piérard. 2005. “[How I Treat ... Atopic Dermatitis by Topical Pimecrolimus (Elidel). The Emerging Paradigm of Calcineurin Inhibitors].” Revue Medicale de Liege 60 (3): 136–40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15884695&authtype=sso&custid=ns315887.